Scienture Holdings, Inc. announced a registered direct offering of 3,225,000 shares of common stock at an offering price of $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting placement agent fees and other offering expenses.
The offering is set to close on August 15, 2025, subject to customary closing conditions.
Offer Details
3,225,000 shares of common stock offered at $1.20 per share.
Gross Proceeds
Approximately $3.9 million expected before deductions.
Closing Date
Offering scheduled to close on August 15, 2025.
Placement Agent
Maxim Group LLC acting as the sole placement agent.
Registration Statement
Offering made under an effective shelf registration statement on Form S-3 (File No. 333-289198).
- The offering provides Scienture Holdings with additional capital to support its operations and growth.
- The involvement of institutional investors signifies confidence in Scienture's future prospects.
The registered direct offering is a significant step for Scienture Holdings, Inc. to raise capital and expand its pharmaceutical operations.